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ABSTRACT
During the dengue virus type 3 (DENV-3) epidemic that occurred in Havana in 2001 to 2002, severe disease was associated with
the infection sequence DENV-1 followed by DENV-3 (DENV-1/DENV-3), while the sequence DENV-2/DENV-3 was associated
with mild/asymptomatic infections. To determine the role of the virus in the increasing severity demonstrated during the epi-
demic, serum samples collected at different time points were studied. A total of 22 full-length sequences were obtained using a
deep-sequencing approach. Bayesian phylogenetic analysis of consensus sequences revealed that two DENV-3 lineages were cir-
culating in Havana at that time, both grouped within genotype III. The predominant lineage is closely related to Peruvian and
Ecuadorian strains, while the minor lineage is related to Venezuelan strains. According to consensus sequences, relatively few
nonsynonymous mutations were observed; only one was fixed during the epidemic at position 4380 in the NS2B gene. Intrahost
genetic analysis indicated that a significant minor population was selected and became predominant toward the end of the epi-
demic. In conclusion, greater variability was detected during the epidemic’s progression in terms of significant minority vari-
ants, particularly in the nonstructural genes. An increasing trend of genetic diversity toward the end of the epidemic was ob-
served only for synonymous variant allele rates, with higher variability in secondary cases. Remarkably, significant intrahost
genetic variation was demonstrated within the same patient during the course of secondary infection with DENV-1/DENV-3,
including changes in the structural proteins premembrane (PrM) and envelope (E). Therefore, the dynamic of evolving viral
populations in the context of heterotypic antibodies could be related to the increasing clinical severity observed during the
epidemic.
IMPORTANCE
Based on the evidence that DENV fitness is context dependent, our research has focused on the study of viral factors asso-
ciated with intraepidemic increasing severity in a unique epidemiological setting. Here, we investigated the intrahost ge-
netic diversity in acute human samples collected at different time points during the DENV-3 epidemic that occurred in
Cuba in 2001 to 2002 using a deep-sequencing approach. We concluded that greater variability in significant minor popu-
lations occurred as the epidemic progressed, particularly in the nonstructural genes, with higher variability observed in
secondary infection cases. Remarkably, for the first time significant intrahost genetic variation was demonstrated within
the same patient during the course of secondary infection with DENV-1/DENV-3, including changes in structural proteins.
These findings indicate that high-resolution approaches are needed to unravel molecular mechanisms involved in dengue
pathogenesis.
Dengue viruses (DENVs) cause the most important arthro-pod-borne viral disease in humans, with latest estimates of
390 million dengue infections per year, of which 96 million
manifest some level of disease severity (1). This figure is more
than three times the dengue burden estimate of the World
Health Organization (2). Latin America has progressively
evolved a region with low dengue endemicity to a region of
hyperendemicity, with local transmission of the four dengue
virus serotypes (DENV 1 to 4) in practically all countries (3).
DENVs are assigned to the genus Flavivirus in the family Flavi-
viridae. The genomes of flaviviruses comprise a single-stranded
RNA molecule encoding three structural proteins, the capsid
(C), premembrane/membrane (PrM/M), and envelope (E),
and seven nonstructural (NS) proteins, NS1, NS2A, NS2B,
NS3, NS4A, NS4B, and NS5 (4). Infection with any DENV
serotype may present as an asymptomatic infection or as a
symptomatic infection ranging from mild to severe illness:
dengue fever (DF) and dengue hemorrhagic fever/dengue
shock syndrome (DHF/DSS) (5) or dengue and severe dengue,
according to the new dengue case classification (2).
The etiology of DHF/DSS has been the subject of research for
Received 19 October 2015 Accepted 5 February 2016
Accepted manuscript posted online 17 February 2016
Citation Rodriguez-Roche R, Blanc H, Bordería AV, Díaz G, Henningsson R,
Gonzalez D, Santana E, Alvarez M, Castro O, Fontes M, Vignuzzi M, Guzman MG.
2016. Increasing clinical severity during a dengue virus type 3 Cuban epidemic:
deep sequencing of evolving viral populations. J Virol 90:4320–4333.
doi:10.1128/JVI.02647-15.
Editor: J. U. Jung
Address correspondence to Rosmari Rodriguez-Roche, rosmari@ipk.sld.cu.
Copyright © 2016 Rodriguez-Roche et al. This is an open-access article distributed
under the terms of the Creative Commons Attribution 4.0 International license.
crossmark
4320 jvi.asm.org May 2016 Volume 90 Number 9Journal of Virology
 o
n
 July 29, 2016 by INSTITUT PASTEUR-Bibliotheque
http://jvi.asm.org/
D
ow
nloaded from
 
over 40 years (6, 7). In Cuba, secondary infection has been impli-
cated as the most relevant risk factor to developing severe disease,
combined with the introduction of DENV strains of Asian origin.
Likewise, other risk factors, including age, genetic background,
and chronic diseases, like bronchial asthma, sickle cell anemia,
and diabetes, have also been implicated in dengue severity (8, 9).
Notably, during two severe epidemics (1981 and 1997) character-
ized by the circulation of only one serotype (DENV-2), 4 and 20
years, respectively, after the massive DENV-1 epidemic, a marked
month-to-month increase in clinical severity was observed in sec-
ondary infection cases (8, 10, 11).
In June 2001, the nationwide dengue case surveillance system
identified a DENV-3 outbreak in Havana City, which eventually
involved 12,889 confirmed cases, including 78 DHF/DSS and
three fatalities (12). Here, we report that significant monthly in-
creases in the proportion of DHF/DSS cases also occurred during
this epidemic, 24 years after the DENV-1 epidemic and 20 years
after one caused by DENV-2. Since the epidemic was circum-
scribed to Havana City, which has an admixed population with
homogenous ethnic composition, and since all severe cases were
in adults, the hypothesis related to the outbreak moving into dif-
ferent regions with different population demographics to explain
the increasing severity was refuted. Likewise, host factors did not
appear to explain this increase because it is not logical to assume
that the most susceptible individuals would all be infected toward
the end of the epidemic.
However, the theory that cross-immunity could play a signifi-
cant role in shaping viral population diversity, selecting for more
fit viruses toward the end of the epidemics that produce severe
dengue, is plausible. Previous studies in this particular context
have suggested that the phenomenon of increasing clinical sever-
ity with the epidemic’s progression could be related to temporary
changes that occur in the virus causing the epidemic (10, 13, 14).
In this regard, little is known about the extent of intrahost genetic
diversity of DENVs in relation to immune status and their
implications for dengue pathogenesis and disease severity. Ini-
tial studies using cloning techniques demonstrated higher
levels of DENV-3 intrahost genetic diversity in patients than
in mosquitoes (15). In addition, the extent and pattern of
DENV-1 diversity during acute infection were related to dis-
ease outcome (16), while no relationship was found for the
same serotype in a different scenario (17). Later on, studies
using deep-sequencing approaches, although in indifferent ep-
idemiological contexts, have shown low genetic diversity in
humans (18, 19). Most recent papers on dengue intrahost di-
versity have been focused on viral population variations during
human/mosquito host switching (20–22).
In the present study, we explored intrahost DENV-3 genetic
diversity in serum samples collected at different time points dur-
ing the 2001-2002 Cuban epidemic, using whole-genome ampli-
fication and next-generation sequencing to determine the role of
the virus in increasing disease severity. Our results demonstrate
that changes in the viral population occurring with the epidemic’s
progression could have an impact on viral fitness.
MATERIALS AND METHODS
Epidemic characterization in terms of dengue severity. The proportion
of DHF/DSS per dengue case was compared every four epidemiological
weeks as an expression of increasing clinical severity, based on confirmed
dengue case figures that were notified during the epidemic period through
the laboratory surveillance system (12). Analysis for a linear trend in pro-
portion was done by a chi-square test using Epinfo, version 3.2. Odds
ratios (OR) were calculated taking the weeks 33 to 36 as a reference be-
cause no DHF/DSS cases were observed in preceding weeks.
Samples. Twenty-two DENV-3 acute positive serum samples corre-
sponding to 21 patients collected at different time points during the 2001-
2002 Cuban epidemic were utilized formolecular characterization (Table 1).
Two samples (Cuba_553_2001 and Cuba_558_2001) correspond to the
same patient. All samples had been processed during the epidemic period
for viral isolation on C6/36 HT cells and identification by indirect im-
mune fluorescence with monoclonal antibodies (23) and then stored at
80°C in the strain bank of the National Reference Laboratory of Virol-
ogy at Pedro Kouri Institute of Tropical Medicine. Informed consent was
obtained from all patients at the moment of sample collection. All cases
were classified clinically at that time as DF or DHF/DSS according to the
Guidelines for Control and Prevention of Dengue and Dengue Hemor-
rhagic Fever in the Americas (24). In addition, the most recent clinical
classification (2)was obtained after analysis of data available in the clinical
records of the patients. Ten patients included in the study, classified as DF
because they did not fulfill the strictWHOcriteria to classify them asDHF
according to the 1997 guidelines, presented warning signs and required
hospitalization. Indeed, they were at risk of severe dengue. However, early
hospitalization policies combined with proper clinical management pre-
vented complications. Patients without warning signs treated at home
were visited daily by the family doctor to accurately define the final disease
outcome. The Institutional Ethical Review Committee of the Pedro Kouri
Institute of Tropical Medicine approved the present study (IRB number
CEI-IPK-13-11).
IgG detection. All samples were processed by an enzyme-linked im-
munosorbent assay (ELISA) inhibition test to determine anti-dengue vi-
rus IgG titers. Samples with titers less than 1/20 were considered primary
infections, and samples with titers higher than 1/1,280, were considered
secondary infections (25).
Sequence of infection. Sera frompatients in the convalescent phase of
the infection were analyzed for neutralizing antibodies to all DENV sero-
types using the 50% endpoint plaque reduction neutralization test de-
scribed byMorens et al. (26), with somemodifications (27). According to
criteria previously established (28), patients with neutralizing antibody
titers of1:30 to only one DENV serotype were considered to have expe-
rienced a primary dengue virus infection. Patients with neutralizing anti-
body titers of 1:30 against two or more serotypes were considered to
have experienced a second or third infection.
Full-length viral genome amplification. Briefly, viral RNA was ex-
tracted from 140 l of serum sample using a QIAamp viral RNA minikit
(Qiagen, Germany). cDNA was synthesized using a Transcriptor High
Fidelity cDNA Synthesis kit (Roche Applied Science, Germany) using 600
M hexamer random primer according to the manufacturer’s instruc-
tions. An aliquot of 3 l of cDNA was subjected to PCR using an Expand
High Fidelity Plus PCR system (Roche Applied Science, Germany) ac-
cording to the manufacturer’s instructions. Two independent DNA li-
braries (a and b) were constructed using two different sets of primers for
each sample. Five pairs of primers were utilized to obtain five overlapping
fragments of 2 to 3 kb (fragments F1a to F5a), covering the complete
genome of the DENV-3 virus as previously published (29). In addition, a
second set of primers was designed (available from the authors on re-
quest); these fragments were named F1b to F5b.
Population diversity determined by deep sequencing. To estimate
the population diversity of variants by deep sequencing, PCR fragments
were purified via a QIAQuick PCR purification kit (Qiagen, Germany),
and total DNA was quantified by Pico Green fluorescence (Invitrogen,
USA). Amplicons were then fragmented using Fragmentase and linked to
Illumina multiplex adapters; they were subjected to clustering and se-
quencing with Illumina cBot and GAIIX technology and analyzed with
established deep-sequencing data analysis tools. Illumina technology was
selected since it is capable of producing enough sequencing data to enable
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identification of rare variants present in as low as a 1:1,000 ratio in samples
of modest reference size. Improvements in accuracy were made with the
ViVAN (Viral Variant ANalysis) pipeline (30), a robust algorithm based
on each variant allele’s initial rate and read qualities, to differentiate be-
tween sequencing errors and actual population variants, facilitating accu-
rate variant assessment for DENV populations. To minimize inaccuracy
due to sequencing errors, alleles at frequencies of 0.1% were analyzed,
while ultrarare variants were discarded.
During the sequencing assembly process, a closely related reference
sequence (DENV-3/EC/BID-V2975/2000) was utilized. This sequence
was selected according to the phylogenetic tree constructed using
DENV-3 consensus sequences obtained by the Sanger method. Once we
were able to assemble the sequence of the first isolate of the epidemic
(Cuba_15_2001), this consensus sequence was used as a reference to an-
alyze minor variants that appeared in DENV-3 samples collected at dif-
ferent time points during the Cuban epidemic. A new statistically signif-
icant variant was considered unique for a particular sample if it appeared
in both independent DNA libraries. Briefly, for each position throughout
the viral genome, base identity and quality score were gathered. Each
variant was determined to be true using a generalized-likelihood ratio test
(used to determine the total number of minority variants), and its allele
rate was modified according to its covering read qualities based on max-
imum-likelihood estimation. Additionally, a confidence interval was cal-
culated for each allele rate. In order to correct for multiple testing, a
Benjamini-Hochberg false-discovery rate of 5% was set (31). Different
ViVAN output files were utilized for analysis, such as synonymous and
nonsynonymous changes for each significantly variable position, orga-
nized by gene and position for the whole viral genome, and a battery of
metrics, including nucleotide substitutionmatrix, transition/transversion
frequencies, and variant allele rates. The variant allele rate is the frequency
of a significant nonreference allele (in this case, a single nucleotide poly-
morphism [SNP]) present in the sample, whether it occurs across the
whole viral genome or in a specific gene. This measurement is a proxy to
calculate heterogeneity of a specific sample. In addition, three files with
pairwise comparisons supplying the mutations found to be different or
common among samples as well as the consensus sequence files were
utilized (30).
Intersample cluster analyses were performed by first computing the
distance matrix among all samples using root mean square deviation
(RMSD) values according to Li et al. (32). Multidimensional scaling
(MDS), with Kruskal’s stress criterion (33), was performed on the dis-
tance matrix to produce a low-dimensional plot of the samples. Dendro-
grams based on complete linkage hierarchical clustering of the distance
matrix were also plotted.
TABLE 2 Increasing clinical severity during the DENV-3 Cuban
epidemic, 2001 to 2002
Parameter
Value for the parameter at the indicated
period (wk)a
22–32 33–36 37–40 41–44 45–48 49–52
No. of confirmed dengue
cases
187 534 1,857 3,185 2,647 2,356
No. of DHF/DSS cases 0 1 6 7 23 32
No. of deaths 0 0 0 2 0 1
Proportion of dengue cases
with DHF/DSS (%)b
0 0.2 0.3 0.2 0.9 1.4
Odds ratio 1 1.72 1.17 4.64 7.25
a Epidemiological weeks span the following months: weeks 22 to 32, June to August
2001; weeks 33 to 36, August to September 2001; weeks 37 to 40, September to October
2001, weeks 41 to 44, October to November 2001; weeks 45 to 48, November to
December 2001; weeks 49 to 52, December 2001 to January 2002.
b Values based on a chi-square test for the linear trend from epidemiological weeks 33
to 36 and weeks 49 to 52 (P 0.05).
TABLE 1 Data of DENV-3 samples collected during the 2001-2002 epidemic
Sample
no. Sample code
Date of sample
collection (day-mo-yr)
No. of days
of illness Municipality
Clinical classification according to:
Type of
infectionWHOa WHO/TDRb
1 Cuba_15_01 5-7-01 1 Playa DF Dengue,WS Secondary
2 Cuba_26_01 15-7-01 2 La Lisa DF Dengue,WS Secondary
3 Cuba_73_01 22-7-01 2 Playa DF Dengue,WS Secondary
4 Cuba_118_01 3-8-01 2 Arroyo Naranjo DF Dengue,WS Primary
5 Cuba_167_01 15-8-01 2 Arroyo Naranjo DF Dengue,WS Primary
6 Cuba_463_01 23-9-01 2 Playa DHF/DSSc Severe dengue Secondary
7 Cuba_492_01 28-9-01 2 Playa DFc Dengue,WS Secondary
8 Cuba_504_01 1-10-01 3 Playa DFc Dengue,WS Secondary
9 Cuba_513_01 2-10-01 3 Playa DFc Dengue,WS Primary
10 Cuba_523_01 5-10-01 2 Playa DFc Dengue,WS Primary
11 Cuba_546_01 15-10-01 2 Marianao DFc Dengue,WS Secondary
12 Cuba_547_01 15-10-01 2 Arroyo Naranjo DFc Dengue,WS Primary
13e Cuba_553_01 21-10-01 2 Marianao DFc Dengue,WS Secondary
14 Cuba_557_01 22-10-01 2 Marianao DFc Dengue,WS Primary
15e Cuba_558_01 21-10-01 4 Marianao DFc Dengue,WS Secondary
16 Cuba_568_01 8-11-01 2 La Lisa DF Dengue,WS Secondary
17 Cuba_580_01 22-11-01 4 La Lisa DHF/DSSc,d Severe dengued Secondary
18 Cuba_16_02 6-1-02 3 Habana Vieja DF Dengue,WS Primary
19 Cuba_11_02 15-1-02 2 Plaza DFc Dengue,WS Secondary
20 Cuba_17_02 20-1-02 2 Centro Habana DF Dengue,WS Secondary
21 Cuba_20_02 20-1-02 2 Centro Habana DF Dengue,WS Secondary
22 Cuba_21_02 21-1-02 1 Centro Habana DF Dengue,WS Primary
a See reference 5. DF, Dengue fever; DHF/DSS, dengue hemorrhagic fever/dengue shock syndrome.
b See reference 2.WS, with warning signs;WS, without warning signs.
c Required hospitalization.
d Fatal case.
e Samples 13 and 15 represent the same patient.
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Consensus sequence analysis. Consensus full polyprotein nucleotide
sequences of eachDENV-3 isolate obtained in the present studywere aligned
using ClustalX (34), together with relevant sequences retrieved from
GenBank (available from the authors on request) such that representative
sequences from all the known DENV-3 genotypes were present. From the
initial data set, identical sequences and known recombinant sequences were
removed fromthealignments.Thisproduceda total data set of 104 sequences
of 10,170 nucleotides in length. Phylogenetic analyses were performed using
Bayesian analysis inMrBayes, version 3.1.2 (35), with aminimum of 20mil-
lion generations and a burn-in of 10%. Stationarity was assessed at effective
sample size (ESS;400) usingTracer, version 1.4.1 (part of the BEASTpack-
age) (36).
FIG1 Bayesian phylogeny of theDENV-3 polyprotein data set, includingCuban isolates from the 2001-2002 epidemic highlighted in gray. All horizontal branch
lengths are drawn to scale. Bar, 0.02 substitutions per site. The tree is midpoint rooted for purposes of clarity only.
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Nucleotide sequence accession numbers. The consensus nucleotide
sequences reported in this study are available inGenBank under accession
numbers KT726340 to KT726361.
RESULTS
Increasing clinical severity during the epidemic. The propor-
tions of DHF/DSS cases per dengue case were compared every
four epidemiological weeks as an expression of increasing clinical
severity. According to epidemiological data the first dengue case
was reported by epidemiological week 22 (beginning of June).
However, the first DHF/DSS case occurred by epidemiological
week 36 (beginning of September). Fromweeks 45 to 48 the num-
ber of confirmed dengue cases had a tendency to decrease while
the proportion of DHF/DSS cases increased notably (P  0.05).
The last sevenDHF/DSS cases appeared during January 2002,with
five of them occurring during the first week. The risk of severe
dengue increased noticeably from September 2001 to January
2002 by 7.25-fold (Table 2). These findings confirmed that in-
creasing clinical severity occurred toward the end of the epidemic.
Notably, the peak of the epidemic occurred in October; however,
the first two fatalities were reported at the end of November 2001,
and the last one was reported at the beginning of January 2002, for
a total of three during the epidemic period.
Phylogenetic analysis. The Bayesian phylogenetic tree con-
structed with complete polyprotein sequences indicated that
all Cuban isolates collected during the 2001-2002 epidemic
grouped within genotype III, introduced in Latin America
since 1994 (Fig. 1). Therefore, as expected, the Nicaraguan
strain (NI_BID_V2420_1994) isolated around this time was lo-
cated at the base of the Latin American group. All major nodes
were statistically reliable according to the estimates of posterior
probability. The phylogenetic tree further suggested that two lin-
eages were circulating in Havana. It was noticeable that most
Cuban isolates (20 isolates) representing the main lineage
formed an independent monophyletic subgroup, closely re-
lated to Peruvian and Ecuadorian isolates from 2000 to 2002,
but two isolates from the beginning of the epidemic-
(Cuba_118_2001 and Cuba_167_2001) appeared slightly dis-
tant, closely related to Venezuelan isolates from 2001.
Genetic variability at the consensus sequence level. Analysis
of nucleotide sequences of the DENV-3 Cuban isolates, excluding
samples Cuba_118_2001 and Cuba_167_2001, corresponding to
a different lineage, revealed that relatively few nonsynonymous
mutations occurred (Table 3).Notably, thesemutationswere gen-
erally unique for particular isolates, suggesting that they were not
fixed within the population during the time of study, except for
the mutation at nucleotide position 4380, which became fixed.
This nonsynonymous mutation led to a conservative amino
acid change of serine to asparagine, namely, S93N that is lo-
cated in the NS2B protein. Puzzlingly, only the first isolate
(Cuba_15_2001) had the S residue at this position, which was
uncommon for DENV-3 strains of any genotype. Being a fairly
indifferent amino acid, serine can reside both within the inte-
rior of a protein and on the protein surface. Its small size means
that it is relatively common within tight turns on the protein
surface, where it is possible for the serine side chain hydroxyl
oxygen to form a hydrogen bond with the protein backbone,
effectively mimicking proline. However, asparagine prefers
generally to be on the surface of proteins, exposed to an aque-
ous environment (37).
Finally, samples Cuba_553_2001 and Cuba_558_2001 col-
TABLE 3 Amino acidic changes at the consensus level among the DENV-3 isolates collected at different time points during the Cuban epidemic,
2001 to 2002
Sample
no. Sample code
Amino acid residue of the viral protein at the indicated position:a
C E NS1 NS2A NS2B NS3 NS4A NS4B NS5
39 198 329 256 4 195 33 59 60 93 60 155 39 18 190 246 250 371 637 830
1 Cuba_15_01 K T V H K A V I T S H V R E I H T R H V
2 Cuba_26_01 N
3 Cuba_73_01 N D
4 Cuba_118_01 N Y E T V N Y I K V R I
5 Cuba_167_01 N Y E T V N Y I K V R I
6 Cuba_463_01 N A
7 Cuba_492_01 N A
8 Cuba_504_01 N
9 Cuba_513_01 N
10 Cuba_523_01 L N Y
11 Cuba_546_01 N
12 Cuba_547_01 A N
13 Cuba_553_01 N
14 Cuba_557_01 A N
15 Cuba_558_01 N
16 Cuba_568_01 N K
17 Cuba_580_01 N
18 Cuba_16_02 I N
19 Cuba_11_02 N
20 Cuba_17_02 A N
21 Cuba_20_02 N
22 Cuba_21_02 N
a The reference sequence of Cuba_15_2001 is shown in boldface. Only substitutions are shown. Samples 4 and 5 correspond to a different lineage.
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lected 2 days apart from the same patient showed identical con-
sensus nucleotide sequences.
Viral population analysis. Synonymous and nonsynonymous
variant allele rates per 10,000 bases at the complete-genome level
were calculated according to time of isolation. An increasing trend
toward the end of the epidemic was observed only for synony-
mous variant allele rates (Fig. 2). Interestingly, in terms of non-
synonymous variant alleles, the viral population analysis indicated
that at position 4380 in the NS2B gene, a significant minor popu-
lation (A, 0.875%; T, 0.0%; C, 0.0%; G, 99.111%) present in the
first isolate collected during the epidemic (Cuba_15_2001) was
selected and became predominant (A, 99.943%; T, 0.0%; C, 0.0%;
G, 0.664%) at the end of the epidemic. Taking into account this
pattern, variants at low frequency (1%) were considered rele-
vant; therefore, unique significantminority variants (0.1%) that
appeared with the epidemic’s progression were analyzed using the
first isolate (Cuba_15_2001) as a reference.
Greater variability was observed in the nonstructural genes
than in the structural genes in terms of significant minority vari-
ants, involvingmainlyNS5,NS3 andNS4B genes, and particularly
toward the end of the epidemic. Across the genome, the number of
positions with significantminority variants (0.1%) ranged from
12 to as high as 48 in both primary and secondary infections with-
out significant differences between these groups (Fig. 3).
However, different results were obtained when higher-fre-
quency minority variants (1%) were analyzed (Fig. 4). Still
greater variability was observed in the nonstructural genes than
in the structural genes, but it was noteworthy that patients with
secondary infections showed greater variability than patients
with primary infections. In addition, patients with secondary
infections presented minority variants in the structural genes
(PrM and E), some of which were nonsynonymous. In contrast,
patients suffering primary infections had only mostly synony-
mous minority variants (1%) in nonstructural genes (Tables
4 and 5).
Intersample cluster analyses using RMSD values based on
MDS showed greater variability with the epidemic’s progression.
Samples with similar characteristics were reflected in the plot by
their close spatial proximity to each other. Isolates collected at the
end of the epidemic were located on the periphery of the plotting
area, indicating higher variability (Fig. 5). Dendrograms using
unique significant minority variants (0.1%,0.5%, and1%)
showed similar results; isolates collected at the very beginning
were closely related and had less genetic variability than late iso-
lates, based on RMSD values (Fig. 6).
Finally, significant minority variants present in samples
Cuba_553_2001 andCuba_558_2001 collected from the same pa-
tient at days 2 and 4 after fever onset were compared (Table 6).
The analysis revealed changes in the viral population structure
during the course of a secondary infection that were well sup-
ported by our data since high-quality sequences were obtained
(Table 6), and similar results were obtained in two independent
DNA libraries (a and b). Two silent nucleotide substitutions, C/T
at position 5371 in NS3 and C/T at position 9142 in NS5, were
found in both samples as the predominant population. Notably,
these variants were present as significant minority variants in the
FIG2 Synonymous variant allele rate per 10,000 bases at the complete-genome level according to time of sample collection during the 2001-2002 epidemic. Data
sets a and b correspond to two different DNA libraries processed for each acute-phase sample through deep sequencing. For the synonymous variant allele rate
in data set a (syna), R2 0.547, and for data set b (synb), R2 0,693; for the linear tendency for data set a, P 1.94e4, and for data set b, P 5.19e6.
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first isolate, Cuba_15_2001. In addition, seven unique significant
minority variants (1%) were found in sample Cuba_
553_2001 that were absent in sample Cuba_558_2001 (six of
which were synonymous). Likewise, six unique significantminor-
ity variants (1%) were found in sample Cuba_558_2001 that
were absent in sample Cuba_553_2001 (four of which were non-
synonymous). Interestingly, significant minority variants in the
sample collected at day 2 corresponded exclusively to nonstruc-
tural genes, while significantminority variants present in the sam-
ple collected at day 4 included nonsynonymous changes in the
PrM, E, and NS5 genes. The change E9D in PrM protein was
located in theN terminus of Pr nearmotif 6, one of the prominent
FIG 3 Number of positions with unique significant minority variants common for sets a and b (0.1%), taking as a reference the first isolate of the DENV-3
Cuban epidemic of 2001 to 2002. Samples are grouped according to type of infection in primary and secondary infections by date of sample collection (Table 1).
UTR, untranslated region.
FIG4 Number of positionswith unique significantminority variants common for sets a and b (1%), taking as a reference the first isolate of theDENV-3Cuban
epidemic of 2001 to 2002. Samples are grouped according to type of infection in primary and secondary infections by date of sample collection (Table 1).
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complementary electrostatic patches in the PrM-E heterodimer.
The changes M199I and A441V in E protein were located in do-
main II and the membrane-proximal stem (EH2), respectively.
The stem has two predicted amphipathic helices that lie half bur-
ied in the outer leaflet of the viral membrane. For fusion to take
place, the stem region must span the length of the domain II re-
gion. In addition, EH2 can affect the expression and stability of its
chaperone PrM (38–40). Finally, the change I517V inNS5 protein
was located in the RNA-dependent RNA polymerase catalytic do-
main (41). Simultaneous with the intrahost genetic diversity ob-
served during the course of infection in this particular patient,
increasing neutralizing titers were observed for DENV-1 (from
1/28 to 1/200) as well for DENV-3 (from1/10 to 1/200) in sam-
ples collected at days 2 and 4 after fever onset. Nevertheless, titers
for DENV-2 and DENV-4 were undetectable (1/10) at days 2
and 4 after fever onset. At day 5, neutralizing titers were consid-
erably elevated against all DENV serotypes.
DISCUSSION
Most epidemiological inferences made to date from genomic se-
quence analysis of RNA viruses, particularly of dengue virus, have
used the consensus sequences of viral populations. However, it is
becoming progressively clearer that increases in fitness and
changes in adaptability are observed without changes in the con-
sensus sequence (42). Next-generation sequencing is greatly ex-
panding the capacity to examine the composition of mutant spec-
tra in infected cells and host organisms with unprecedented
accuracy. Therefore, significant progress in the understanding of
viral population dynamics has been made in recent years (43, 44).
In dengue virus, the association between intrahost diversity
and disease outcome is an area of active investigation (7). Unfor-
tunately, the comparison among available publications is complex
and inadequate, taking into account that different genes are
examined by dissimilar approaches and that dissimilar epide-
miological settings are evaluated in terms of DENV circulating
serotypes/genotypes and the immunological background of the
population.
Based on the evidence that dengue virus fitness is context de-
pendent, better characterization of viral evolution in exceptional
epidemiological settings could contribute to a better understand-
ing of dengue pathogenesis. However, few studies have been able
to properly demonstrate that the dynamics of dengue disease se-
verity is determined by the interplay between viral genetics and
serotype-specific immunity (10, 14, 45) because dengue is hyper-
endemic in most tropical countries. The present study is unique
because it is the first that characterizes the entire viral population
of DENV-3 from samples collected at different time points during
a single epidemic taking place in a well-characterized epidemio-
logical context with only one serotype circulating following a 20-
year period of total absence of dengue, with a demonstrated intra-
epidemic increase in clinical severity.
Phylogenetic analyses based on a full-length consensus se-
quence were consistent with those previously obtained using E
gene sequences, showing that the etiological agent of the epidemic
belongs to genotype III (46). However, the higher number of sam-
ples studied at present revealed that two introductions occurred
during this epidemic period. Presumably, according to the data
set, the transmission of the minor lineage represented by two iso-
lates was short-lived. While we cannot exclude an undersampling
effect, this minor lineage was detected only in the Arroyo Naranjo
municipality at the beginning of the epidemic. Afterwards, only
isolates genetically related to the main lineage were collected at
this location. Clearly, the minor lineage could have been elim-
inated due to vector control actions in a particular area of
Arroyo Naranjo close to the time of introduction. Alterna-
tively, the minor lineage could have been out-competed due to
a lower viral fitness than that of the main lineage. Previous
studies on the biological properties of DENV-3 isolated during
this epidemic indicated that strains corresponding to the less rep-
resentative lineage (Cuba_118_2001 and Cuba_167_200) col-
lected in ArroyoNaranjo weremore sensitive to high temperature
(39°C) during replication in BHK-21 cells than strains corre-
sponding to the main lineage (47). In addition, a study on the
calculation of the basic reproductive number, R0 in different mu-
nicipalities ofHavana indicated that ArroyoNaranjomunicipality
had the lowest R0 estimated value, i.e., 1.97 (95% confidence in-
TABLE 4 Unique significant variants (1%) common for set a and b for primary infection cases taking as a reference the first isolate obtained
during the Cuban epidemic, 2001 to 2002
Sample
no. Feature
Position
(nt)c
Reference
allele
Set a variant Set b variant
Allele
Amino
acid no. Change
Frequency
(%) Allele
Amino
acid no. Change
Frequency
(%)
9 a          
10 NS1 3424 C T 344 Synonymous¡ N 1.145 T 344 Synonymous¡ N 1.037
NS1 2887 C T 165 Synonymous¡ T 1.079 T 165 Synonymous¡ T 0.966
12 NS5 9803 C T 754 Synonymous¡ L 4.539 T 754 Synonymous¡ L 4.371
NS5 7866 C T 108 P¡ L 1.538 T 108 P¡ L 1.536
14 NS1 2924 C T 178 Synonymous¡ L 5.312 T 178 Synonymous¡ L 6.398
NS3 5371 C T 293 Synonymous¡ A 1.086 T 293 Synonymous¡ A 0.134
18 3= UTR 10369 G T *b * 1.641 T * * 2.097
22           
a Minority variants represent1%.
b Indicates position in noncoding region of the 3= untranslated region (UTR).
c nt, nucleotide.
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TABLE 5 Unique significant variants (1%) common for set a and b for secondary infection cases taking as a reference the first isolate obtained
during the Cuban epidemic, 2001 to 2002a
Sample
no. Feature
Position
(nt)b
Reference
allele
Set a variant Set b variant
Allele
Amino
acid no. Change
Frequency
(%) Allele
Amino
acid no. Change
Frequency
(%)
2 3= UTR 10404 G A *c * 11.859 A * * 12.027
3 NS4B 6853 G C 18 E¡ D 64.984 C 18 E¡D 62.998
NS5 8212 C T 223 Synonymous¡ G 53.212 T 223 Synonymous¡ G 0.905
2K peptided 6751 C T 7 Synonymous¡ L 26.347 T 7 Synonymous¡ L 26.578
NS3 5956 C T 488 Synonymous¡H 24.414 T 488 Synonymous¡H 24.625
6 PrM 519 C T 35 T¡ I 5.444 T 35 T¡ I 4.605
NS5 8080 T C 179 Synonymous¡ I 3.055 C 179 Synonymous¡ I 1.961
NS5 9743 C T 734 Synonymous¡ L 2.825 T 734 Synonymous¡ L 1.11
7 NS5 10000 G A 819 Synonymous¡ E 52.534 A 819 Synonymous¡ E 52.01
3UTR 10481 C T * * 27.601 T * * 27.616
NS3 5098 G A 202 Synonymous¡ R 6.53 A 202 Synonymous¡ R 7.952
NS2A 3531 G T 28 G¡ V 1.883 T 28 G¡ V 2.237
3UTR 10359 C T * * 1.881 T * * 1.805
NS5 9265 C T 574 Synonymous¡ N 1.339 T 574 Synonymous¡ N 1.423
NS4B 7366 C A 189 Synonymous¡ A 1.093 A 189 Synonymous¡ A 1.417
8 NS2B 4294 G A 64 Synonymous¡ E 7.278 A 64 Synonymous¡ E 7.562
11 E 1834 G A 307 Synonymous¡K 99.597 A 307 Synonymous¡K 99.93
E 991 G A 26 Synonymous¡ E 99.584 A 26 Synonymous¡ E 99.862
NS5 10049 G A 836 V¡ I 7.903 A 836 V¡ I 7.418
NS5 10223 G C 894 E¡ Q 6.094 C 894 E¡ Q 6.061
13 NS5 9142 C T 533 Synonymous¡D 99.288 T 533 Synonymous¡D 98.715
NS3 5371 C T 293 Synonymous¡ A 96.832 T 293 Synonymous¡ A 99.878
NS5 9985 C T 814 Synonymous¡ N 3.203 T 814 Synonymous¡ N 3.15
NS4B 7012 G A 71 Synonymous¡ Q 1.723 A 71 Synonymous¡ Q 1.678
NS5 7975 G A 144 Synonymous¡ L 1.511 A 144 Synonymous¡ L 1.686
NS5 7744 G A 67 Synonymous¡ E 1.472 A 67 Synonymous¡ E 1.484
NS3 5326 C T 278 Synonymous¡ N 1.386 T 278 Synonymous¡ N 1.003
NS4B 7366 C T 189 Synonymous¡ A 1.259 T 189 Synonymous¡ A 0.921
NS2A 3500 C T 18 L¡ F 0.983 T 18 L¡ F 1.474
15 NS5 9142 C T 533 Synonymous¡D 98.963 T 533 Synonymous¡D 97.096
NS3 5371 C T 293 Synonymous¡ A 97.515 T 293 Synonymous¡ A 99.666
NS2B 4315 C T 71 Synonymous¡ S 3.495 T 71 Synonymous¡ S 5.037
E 1510 G A 199 M¡ I 2.366 A 199 M¡ I 2.212
NS5 9092 A G 517 I¡ V 1.579 G 517 I¡ V 1.941
PrM 442 G T 9 E¡ D 1.114 T 9 E¡ D 1.283
NS1 3373 C T 327 Synonymous¡ D 1.096 T 327 Synonymous¡ D 1.032
E 2235 C T 441 A¡ V 0.914 T 441 A¡ V 0.902
16 NS5 8655 G A 371 R¡ K 99.491 A 371 R¡ K 98.923
NS3 6184 C T 564 Synonymous¡ C 6.696 T 564 Synonymous¡ C 6.419
NS4B 7444 C A 215 Synonymous¡ T 1.848 A 215 Synonymous¡ T 2.41
17 NS1 3310 G A 306 Synonymous¡K 99.055 A 306 Synonymous¡K 99.847
NS5 8428 C T 295 Synonymous¡ D 13.026 T 295 Synonymous¡ D 96.876
NS5 8875 C T 444 Synonymous¡ G 2.936 T 444 Synonymous¡ G 0.075
NS5 9127 C T 528 Synonymous¡ A 1.875 T 528 Synonymous¡ A 0.102
3UTR 10283 C T * * 1.817 T * * 0.067
NS5 8659 C T 372 Synonymous¡ V 1.143 T 372 Synonymous¡ V 0.086
NS5 8743 G A 400 Synonymous¡ K 0.894 A 400 Synonymous¡ K 0.09
NS5 7594 A G 17 Synonymous¡ L 0.856 G 17 Synonymous¡ L 1.16
19 NS4A 6574 T C 75 Synonymous¡ G 1.48 C 75 Synonymous¡ G 1.116
3UTR 10661 A G 0.6 G 0.838
(Continued on following page)
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terval [CI], 1.94 to 2.01) whereas Boyeros (48), one of the last
municipalities affected by the epidemic, had an R0 of 61.06 (95%
CI, 60.44 to 61.68).
Considering the main lineage as the one involved in the phe-
nomenon of increasing clinical severity, temporary changes that
appear at the consensus level in the 20DENV-3 samples conform-
ing to this lineage were analyzed. Contrary to expectations, the
clear pattern of evolution observed during the 1997 Cuban epi-
demic (14) was not demonstrated here. A unique amino acid
change, S93N in NS2B, differentiates all the studied isolates from
the first isolate of the epidemic. Interestingly, only the first isolate
had serine at this position, which is uncommon for DENV of any
serotype. However, according to deep sequencing, the genetic
variant coding for the commonmotif asparagine was also present
in the first isolate as a minor variant (1%).The fact that this
motif remains invariant for DENV-3 at deeper phylogenetic levels
suggests that it is favored in nature. Importantly, the replication of
DENV requires the correct processing of the polyprotein by the
viral NS3 protease (NS3pro). For full enzymatic activity NS3pro
requires the hydrophilic part of the integral membrane protein
NS2B as a cofactor (residues 49 to 95), which includes the position
of change (S93N) (49–51).
In contrast to the low variation observed at the consensus level
with the epidemic’s progression, the viral population analysis
from patients infected at different time points during the epi-
demic revealed greater variability in terms of significant minority
variants in the nonstructural genes than in structural genes, par-
TABLE 5 (Continued)
Sample
no. Feature
Position
(nt)b
Reference
allele
Set a variant Set b variant
Allele
Amino
acid no. Change
Frequency
(%) Allele
Amino
acid no. Change
Frequency
(%)
20 NS3 5791 G A 433 Synonymous¡V 96.402 A 433 Synonymous¡V 99.509
PrM 652 G T 79 Synonymous¡ T 4.65 A 79 Synonymous¡ T 0.073
3UTR 10514 G C * * 3.956 C * * 4.416
NS3 4685 C T 65 Synonymous¡ L 3.66 T 65 Synonymous¡ L 0.286
3UTR 10577 A C * * 2.459 C * * 2.533
2K peptide 6769 C A 13 Synonymous¡ G 2.048 A 13 Synonymous¡ G 2.463
21 NS5 8212 C T 223 Synonymous¡ G 39.457 T 223 Synonymous¡ G 97.343
NS4A 6700 G T 117 Synonymous¡ V 8.487 T 117 Synonymous¡ V 8.528
NS4B 6853 G C 18 E¡ D 1.086 C 18 E¡ D 0.797
a Boldface indicate that these variants became predominant in the particular patient.
b nt, nucleotide.
c Indicates positions in noncoding region of the 3= untranslated region (UTR).
d 2K peptide, the DENV 2K-signal sequence is a 17-amino-acid peptide linking NS4A with NS4B.
FIG 5 Multidimensional scaling using root mean square deviation (RMSD)
values calculated using significant minority variants (1%) for data set a (red
dots) and b (blue dots). Numbers represent the 20 studied samples ordered by
collection time, as indicated in Table 1. Samples 4 and 5 that correspond to a
different lineage were excluded.
FIG 6 Dendrogram clustering of Cuban isolates collected at different time
points during the 2001-2002 epidemic using an RMSD-based distance matrix
including data sets a and b. Samples that correspond to a different lineage were
excluded.
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ticularly toward the end of the epidemic. However, it is remark-
able that the increasing trend toward the end of the epidemic was
observed only for synonymous mutations, except for the muta-
tion in NS2B. Nonetheless, its implication for viral fitness should
not be underestimated. Previous studies on vesicular stomatitis
virus indicate that a significant fraction of silentmutations are not
neutral and can significantly contribute to adaptation since a large
part of this sequence space is under natural selection, with an
impact on viral fitness (52). Likewise, a recent study that accu-
rately describes poliovirus populations demonstrated that a sig-
nificant fraction of synonymous changes are subject to strong se-
lection (44). Indeed, there is evidence thatmany synonymous sites
in RNA viruses are not neutral and clearly impact viral fitness
(53, 54).
According to Domingo et al., the advantage of a broad mutant
spectrum lies in the increased capacity of the viral population to
find portions of sequence space in which to increase its fitness
(55). In the present study, viral population analysis also showed
greater variability in patients with secondary infections, including
significant minority variants (1%) that imply changes in the
structural genes not present in patients with primary infections.
One of the most striking observations from this study was the
intrahost genetic variation observed within the same patient dur-
ing the course of infection. The viral population changed in 2 days;
remarkably, new variants that arose on day 4 presented nonsyn-
onymous changes at the structural genes PrM and E. Moreover,
changes in the antibody response profile were demonstrated dur-
ing the acute phase in this patient.
Could this variability depend on the immunity of the patient?
According to previous seroepidemiological studies, all severe cases
observed during the 2001-2002 Cuban epidemic had the sequence
of DENV-1 infection followed by DENV-3 (DENV-1/DENV-3)
or experienced tertiary infection (DENV-1/DENV-2/DENV-3)
(56). However, the infection sequence DENV-2/DENV-3 was as-
sociatedwith asymptomatic infection ormild disease (57). Similar
results were observed in a different epidemiological setting (58),
and it is suggested that antibodies against DENV-2 could have the
ability to neutralize and downregulate DENV-3 infections. In ac-
cordance, a recent study that characterized the antigenic diversity
in the DENV types by antigenic maps constructed from neutral-
izing antibody titers has shown that whereas DENV isolates are
usually located closer to other viruses of the same type, some vi-
ruses, both modern and historical, have greater antigenic resem-
blance to viruses of a different type than to some viruses of the
same type (59). Therefore, the viral population transmitted to a
healthy individual from an infected mosquito may vary depend-
ing on the immunological background of the previous individual
on which the mosquito fed. Likewise, the immunological back-
ground of the new human host could have an effect on the viral
population during the course of infection. Recently, Sim et al.
used whole-genome amplification and next-generation sequenc-
ing to characterize DENV intrahost genetic diversity in both pa-
tient-derived and matched-mosquito-derived virus populations.
Mosquitoes were infected by direct feeding on patients, enabling
the authors to track changes in viral populations during human-
to-mosquito transmission. However, changes in viral populations
during transmission from mosquito back to human were not ex-
amined, and the immunological background of the patients en-
rolled in the study was not determined (20).
In the present situation, the DENV-3 mutant spectrum could
be replicating in total absence of DENV heterologous antibodies
during many cycles of primary infections since a large part of the
population was naive (at least all individuals born after 1981).
Alternatively, during secondary infections in the sequenceDENV-
TABLE 6 Unique significant variants (1%) common for set a and b present in two samples corresponding to the same patient at days 2 and 4 after
fever onset, taking as a reference the first isolate obtained during the Cuban epidemic, 2001 to 2002a
Sample and
feature
Position
(nt)b
Read
coveraged
Reference
allele
Set a variant Set b variant
Allele
Amino
acid no. Change
Frequency
(%) Allele
Amino
acid no. Change
Frequency
(%)
Cuba_553_2001
NS5 9142 30,246 C T 533 Synonymous¡D 99.288 T 533 Synonymous¡D 98.715
NS3 5371 8,024 C T 293 Synonymous¡ A 96.832 T 293 Synonymous¡ A 99.878
NS5 9985 30,249 C T 814 Synonymous¡ N 3.203 T 814 Synonymous¡ N 3.15
NS4B 7012 16,819 G A 71 Synonymous¡ Q 1.723 A 71 Synonymous¡ Q 1.678
NS5 7975 19,551 G A 144 Synonymous¡ L 1.511 A 144 Synonymous¡ L 1.686
NS5 7744 18,047 G A 67 Synonymous¡ E 1.472 A 67 Synonymous¡ E 1.484
NS3 5326 8,654 C T 278 Synonymous¡ N 1.386 T 278 Synonymous¡ N 1.003
NS4B 7366 15,691 C T 189 Synonymous¡ A 1.259 T 189 Synonymous¡ A 0.921
NS2A 3500 12,713 C T 18 L¡ F 0.983 T 18 L¡ F 1.474
Cuba_558_2001
NS5 9142 13,986 C T 533 Synonymous¡D 98.963 T 533 Synonymous¡D 97.096
NS3 5371 18,626 C T 293 Synonymous¡ A 97.515 T 293 Synonymous¡ A 99.666
NS2B 4315 27,529 C T 71 Synonymous¡ S 3.495 T 71 Synonymous¡ S 5.037
E 1510 24,416 G A 199 M¡ I 2.366 A 199 M¡ I 2.212
NS5 9092 12,493 A G 517 I¡ V 1.579 G 517 I¡ V 1.941
PrM 442c 19,513 G T 9 E¡ D 1.114 T 9 E¡ D 1.283
NS1 3373 18,492 C T 327 synonymousD 1.096 T 327 Synonymous¡ D 1.032
E 2235 30,874 C T 441 A¡ V 0.914 T 441 A¡ V 0.902
a Boldface indicate that this variant became predominant.
b nt, nucleotide.
c Variant A (synonymous¡ E) at position PrM 442 was detected in sample Cuba_553_2001 at a frequency of 0.1% (day 2).
d Read coverage, the average number of reads that align to each base of the reference sequence.
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1/DENV-3, higher viral load could be expected via antibody-de-
pendent enhancement. Viral load, together with population ge-
netic heterogeneity, permits exploration of sequence space for a
fitness increase. As viral fitness is environment and population
size dependent, it can change according to the immunological
landscape.
The emergence of significantminority variants with changes in
the structural proteins PrM and E late during the acute phase of
the disease in a secondary infection case (DENV-1/DENV-3) is
described for the first time in dengue. However, its implications
concerning pathogenesis should be examined with a higher num-
ber of well-characterized serial samples, with data including the
immunological background of the patients. The high-resolution
analysis of intrahost genetic diversity published by Thai et al. in
serial plasma samples taken from 17 patients infected with
DENV-1 revealed that nucleotide sequence diversities of viral
populations were very low, ranging from 0 to 0.0013 among
different samples collected from the same patient (17). While
this study explored only the E gene (exclusively the fragment
coding domain III) and used cloning techniques rather than
deep sequencing, its observations fit within the results of the
present study, which observed the lowest diversity in the struc-
tural genes. Moreover, the significant minority variants with
changes in the E gene that emerged in the same patient late
during the course of infection did not involve domain III. Lack
of diversity in the E gene has also been attributed to strong
purifying selection (60).
In conclusion, our results suggest that changes in the viral pop-
ulation swarm occurred with the epidemic’s progression and that
these changes could have had an impact on viral fitness. Therefore,
the dynamics of evolving viral populations in the context of het-
erotypic antibodies could be related to the increasing clinical
severity observed during dengue epidemics. Definitely, new ex-
periments are required to prove in vivo and/or ex vivo the role
of particular mutations on the increased viral fitness toward the
end of the epidemic. In this regard, the impact of synonymous
alleles deserves further study, focused on the biological basis of
the selective advantage of silent mutations in DENVs. More
importantly, studies addressing the extent and pattern of intra-
host genetic diversity during the course of dengue secondary
infections using deep-sequencing approaches should be tack-
led to unravel molecular mechanisms involved in dengue virus
pathogenesis.
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